Impero (IMPERO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
27 Jul, 2026Executive summary
Achieved 20% year-over-year ARR growth, reaching DKK 48.3M by end of Q1 2026, with net new ARR of DKK 2.1M and positive EBITDA for the quarter.
Net Revenue Retention at 107% reflects strong upsell and low churn, with continued expansion in DACH and Northwestern Europe.
Strong cash flow from operations at DKK 9.2M, cash position improved to DKK 26.5M, and cash burn to net new ARR ratio improved to 0.3.
Continued investment in commercial organization, especially in the DACH region, which led growth with 27% ARR increase and accounted for 44% of total ARR.
Major product advances included launch of Entity Management and enhancements to Control Testing modules, with first AI features introduced in May 2026.
Financial highlights
Revenue rose 18% to DKK 11.8M in Q1 2026 compared to Q1 2025; gross profit margin remained stable at 97%.
EBITDA improved to DKK 0.4M from DKK -2.8M in Q1 2025.
Operating loss (EBIT) improved to negative DKK 0.4M from negative DKK 3.7M year-over-year.
Other external expenses decreased by 14% and staff costs by 5% year-over-year.
Cash at period end was DKK 26.5M, up DKK 7.7M from year-end 2025, with no interest-bearing debt.
Outlook and guidance
2026 ARR guidance set at DKK 53M–57M, representing 15–23% growth.
EBITDA guidance upgraded to DKK 0–2M for 2026, reflecting efficiency gains and timing of commercial hires.
Assumes effective go-to-market execution, high retention, timely hiring, and stable macroeconomic conditions.
Latest events from Impero
- 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 202427 Jul 2026 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 202427 Jul 2026 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 202427 Jul 2026 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 202527 Jul 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 202527 Jul 2026 - Record ARR growth, positive EBITDA, and strong DACH performance drive raised 2025 outlook.IMPERO
Q3 202527 Jul 2026 - ARR grew 19% to DKK 46.2M in 2025, with EBITDA improving and churn at a low 1%.IMPERO
Q4 202527 Jul 2026 - Entity Management, AI features, and Control Health drive upcoming platform enhancements.IMPERO
Investor update24 Jun 2026 - Strong ARR growth, AI-driven strategy, and all board proposals approved amid market uncertainties.IMPERO
AGM 202615 Apr 2026